Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
GE Vernova
GEV
|
+$2.13B |
| 2 |
Hershey
HSY
|
+$1.68B |
| 3 |
NVIDIA
NVDA
|
+$1.54B |
| 4 |
Capital Group Municipal Income ETF
CGMU
|
+$1.04B |
| 5 |
Accenture
ACN
|
+$994M |
Top Sells
| 1 |
CME Group
CME
|
+$1.65B |
| 2 |
Comcast
CMCSA
|
+$1.43B |
| 3 |
Keurig Dr Pepper
KDP
|
+$1.02B |
| 4 |
Microsoft
MSFT
|
+$953M |
| 5 |
Dollar General
DG
|
+$879M |
Sector Composition
| 1 | Technology | 25.6% |
| 2 | Industrials | 14.13% |
| 3 | Financials | 13.88% |
| 4 | Healthcare | 11.61% |
| 5 | Communication Services | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Structure Therapeutics
GPCR
$1.2B
| $66.5M | 0.01% |
1,516,022
+17,378
| +1% | +$763K |
|
302
Core & Main
CNM
$9.28B
| $66.3M | 0.01% |
1,493,158
-5,230,298
| -78% | -$232M |
|
303
Apollo Global Management Series A
APO.PRA
$2.09B
| $66M | 0.01% |
970,400
| – | – |
|
304
Wyndham Hotels & Resorts
WH
$6.55B
| $65.2M | 0.01% |
834,303
+77,098
| +10% | +$6.02M |
|
305
NMI Holdings
NMIH
$3.08B
| $62.5M | 0.01% |
1,518,517
| – | – |
|
|
LOMA
306
Loma Negra
LOMA
$888M
| $60.5M | 0.01% |
7,500,613
-171,645
| -2% | -$1.38M |
|
307
Moody's
MCO
$91.9B
| $60.1M | 0.01% |
126,679
+11
| +0% | +$5.22K |
|
308
Cemex
CX
$13.6B
| $59.5M | 0.01% |
9,751,428
-5,671,151
| -37% | -$34.6M |
|
309
Nice
NICE
$8.82B
| $59.3M | 0.01% |
341,609
-287,501
| -46% | -$49.9M |
|
310
Phreesia
PHR
$1.45B
| $59.1M | 0.01% |
2,593,063
| – | – |
|
311
Arcosa
ACA
$4.67B
| $59.1M | 0.01% |
623,503
+211,560
| +51% | +$20M |
|
312
SouthState Bank Corporation
SSB
$10.2B
| $58M | 0.01% |
596,520
| – | – |
|
313
Teva Pharmaceuticals
TEVA
$22.9B
| $57.3M | 0.01% |
3,180,141
-1,332
| -0% | -$24K |
|
314
Herc Holdings
HRI
$4.2B
| $56.3M | 0.01% |
353,219
+29,020
| +9% | +$4.63M |
|
315
Rubrik
RBRK
$14.7B
| $56.3M | 0.01% |
1,750,000
| – | – |
|
316
Bank of Montreal
BMO
$90.5B
| $55.9M | 0.01% |
619,029
+187
| +0% | +$16.9K |
|
|
GMS
317
DELISTED
GMS Inc
GMS
| $55.4M | 0.01% |
611,792
| – | – |
|
318
Live Oak Bancshares
LOB
$1.67B
| $55M | 0.01% |
1,161,176
+443,056
| +62% | +$21M |
|
|
RAPP
319
Rapport Therapeutics
RAPP
$1.1B
| $53.3M | 0.01% |
2,602,529
-2
| -0% | -$41 |
|
320
Four Corners Property Trust
FCPT
$2.66B
| $53M | 0.01% |
1,807,880
| – | – |
|
321
Capital Group Core Bond ETF
CGCB
$2.98B
| $51.7M | 0.01% |
1,919,559
+1,812,473
| +1,693% | +$48.8M |
|
322
Citizens Financial Group
CFG
$22.4B
| $51.6M | 0.01% |
1,255,314
-5,597,045
| -82% | -$230M |
|
323
Agilon Health
AGL
$443M
| $51M | 0.01% |
12,985,578
+541,442
| +4% | +$2.13M |
|
324
Aaon
AAON
$6.7B
| $50.6M | 0.01% |
468,915
+17,745
| +4% | +$1.91M |
|
325
Yeti Holdings
YETI
$2.88B
| $50.6M | 0.01% |
1,232,100
| – | – |
|